BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14711771)

  • 1. Implementation of IMRT in the radiotherapy department.
    McNair HA; Adams EJ; Clark CH; Miles EA; Nutting CM
    Br J Radiol; 2003 Dec; 76(912):850-6. PubMed ID: 14711771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical experience with intensity-modulated radiotherapy.
    James HV; Scrase CD; Poynter AJ
    Br J Radiol; 2004 Jan; 77(913):3-14. PubMed ID: 14988132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance for 3D conformal radiation therapy.
    Purdy JA; Harms WB
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():2-7. PubMed ID: 9810330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer.
    Wu VW; Sham JS; Kwong DL
    Br J Radiol; 2004 Jul; 77(919):568-72. PubMed ID: 15238403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.
    Chung HT; Lee B; Park E; Lu JJ; Xia P
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1167-74. PubMed ID: 18234440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D treatment planning and intensity-modulated radiation therapy.
    Purdy JA
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):155-68. PubMed ID: 10550841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIFT: a method to verify the IMRT fluence delivered during patient treatment using an electronic portal imaging device.
    Vieira SC; Dirkx ML; Heijmen BJ; de Boer HC
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):981-93. PubMed ID: 15465217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
    Zhang F; Zheng M
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer.
    Boehmer D; Bohsung J; Eichwurzel I; Moys A; Budach V
    Radiother Oncol; 2004 Jun; 71(3):319-25. PubMed ID: 15172148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-specific IMRT verification using independent fluence-based dose calculation software: experimental benchmarking and initial clinical experience.
    Georg D; Stock M; Kroupa B; Olofsson J; Nyholm T; Ahnesjö A; Karlsson M
    Phys Med Biol; 2007 Aug; 52(16):4981-92. PubMed ID: 17671348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3D-CRT and intensity modulated radiation therapy (IMRT)].
    Hatano K; Narita Y; Araki H; Sakai M
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2050-5. PubMed ID: 14712764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implementation of tangential field intensity modulated radiation therapy (IMRT) using sliding window technique and dosimetric comparison with 3D conformal therapy (3DCRT) in breast cancer.
    Selvaraj RN; Beriwal S; Pourarian RJ; Lalonde RJ; Chen A; Mehta K; Brunner G; Wagner KA; Yue NJ; Huq SM; Heron DE
    Med Dosim; 2007; 32(4):299-304. PubMed ID: 17980832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It is necessary to validate each individual IMRT treatment plan before delivery. For the proposition.
    Ramsey C
    Med Phys; 2003 Sep; 30(9):2271-2. PubMed ID: 14528945
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
    Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It is necessary to validate each individual IMRT treatment plan before delivery. Against the proposition.
    Dube S
    Med Phys; 2003 Sep; 30(9):2272-3. PubMed ID: 14528946
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
    Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
    Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.